Shanghai Aladdin Biochemical Technology’s IPO debut on SSE STAR Market today
Oct 26, 2020 (China Knowledge) - Shanghai Aladdin Biochemical Technology (688179) to start trading on the Shanghai STAR Market today, at a public offering price of RMB 19.43 per share, raising RMB 490.28 mln. Its initial listing shares account for 25% of total outstanding shares. The company’s initial price-to-earning ratio (PE) stands at 30.79.
Western Securities acted as the lead underwriter and sponsor for the IPO.
Earlier, Shanghai Aladdin Biochemical Technology said its IPO was 3,313 times oversubscribed. Since 2019 to date, A-shares IPOs achieved median oversubscription of 2,814 times and the highest at 9,194 times. For subsequent 30-day trading the performances can be obtained from our China IPO Weekly.
Shanghai Aladdin Biochemical Technology Co Ltd is headquartered in Shanghai, China (Mainland) and is a manufacturer of pharmaceutical preparation. The company was founded in 2009.
In financial year 2019, Shanghai Aladdin Biochemical Technology garnered a total revenue of RMB 209.6 mln, up 26% YoY. In terms of net income, it achieved RMB 74 mln, up 19% YoY. Accordingly, return on equity (ROE) and return on asset (ROA) stood at 19.04% and 16.87% respectively, earning per share (EPS) of 0.84 RMB.
Copyright © 2018 www.chinaknowledge.com
Send feedback or comments to: email@example.com
For more news, financial weekly reports, business guides to China and other premium information, subscribe to China Knowledge today: www.chinaknowledge.com
To access our page on Bloomberg, type CKFI